Skip to content

Postprandial Effects of Walnut Components Versus Whole Walnuts on Cardiovascular Disease (CVD) Risk Reduction

Postprandial Effects of Walnut Components vs Whole Walnuts on Oxidative Stress, Inflammation, Platelet Function, and Endothelial Function in Volunteers With Moderate Hypercholesterolemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00938340
Enrollment
20
Registered
2009-07-13
Start date
2007-08-31
Completion date
2009-05-31
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

Cardiovascular Disease

Brief summary

The purpose of this study is to evaluate the acute, postprandial effects and mechanism of action of various walnut components (separated nut skins, de-fatted nut meat, nut oil) versus whole walnuts on oxidative stress, inflammation and measures of platelet and endothelial function in healthy adults with moderately elevated cholesterol levels.

Detailed description

Walnuts contain high contents of polyunsaturated fatty acids (PUFA), particularly linoleic acid and linolenic acid. The high PUFA content has been suggested to reduce CVD risk through decreasing total and LDL-cholesterol concentrations, and increasing HDL-C concentrations. In addition, walnuts are rich in substances such as ellagic acid (a polyphenol), antioxidants, vitamin E, fiber, essential fatty acids, flavanoids, and phenolic acids. Polyphenolic compounds are believed to have multiple biological effects influencing oxidative stress, platelet function, inflammation, and cancer initiation and propagation. There is interest in identifying foods with these and other favorable compounds to test their efficacy in real world settings to further understand their role in the human diet. Despite positive benefits found in consumption of the walnuts, it is not known which specific component of the walnut (i.e., whole walnut, walnut skin, defatted walnut, or walnut oil) is most beneficial to health. The investigators hypothesize that maximum improvements in oxidative stress, inflammatory markers, platelet and endothelial function will be observed following consumption of the whole nut versus isolated walnut components, thereby leading to a recommendation to consume walnuts. In addition, results from the research proposed will provide new information about the antioxidant, inflammatory, platelet activity and endothelial effects of the different walnut components and the synergistic effects these components have in the postprandial state.

Interventions

DIETARY_SUPPLEMENTWalnut meat

Separated, ground walnut de-fatted nut meat incorporated into inert food carrier

DIETARY_SUPPLEMENTWalnut Oil

Walnut oil extracted from nut meat and incorporated into inert food carrier

DIETARY_SUPPLEMENTWalnut Skins

Separated, ground walnut skins incorporated into inert food carrier

DIETARY_SUPPLEMENTWhole walnut

85g whole walnuts, ground, incorporated into inert food carrier

Sponsors

Penn State University
Lead SponsorOTHER
California Walnut Commission
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 21 - 60 years * Body mass index 25-39 kg/m2 * LDL cholesterol \>110 mg/dL * \<95 percentile for age and gender for both (based on NHANES data) * TG \< 350 mg/dL

Exclusion criteria

* High alcohol consumption \> 21 units/week (female subjects) or \> 28 units/week (male subjects) * Intake of vitamin and mineral supplements within the past 3 weeks or unwillingness to discontinue for 3 weeks prior to screening and for entire study. * Use of prescription cholesterol-lowering or blood pressure-lowering medications during the study * Intake of other putative cholesterol-lowering supplements (excl. psyllium, fish oil capsules, soy lecithin, phytoestrogens) * Intake of anti-inflammatory medications (containing aspirin or NSAIDS) on a regular basis or if an acute intake, within 48 hours of a test day * Diabetes, liver, kidney, thyroid (unless controlled and stable on replacement medication) or other endocrine disorders from self-reported medical history * Treatment with drugs acting on the gut, such as ezetimibe, bile acid-binding resins, orlistat * Dietary restrictions such as a medically prescribed diet, or a slimming diet prior to or during the trial * Weight loss or gain of 10% body weight or more during a period of 6 months before pre-study examination. * Blood/plasma donation for reason(s) other than the present study prior to the study (1 month for a male subject or 2 months for a female subject), or during the study * Lactation 6 weeks before the start of and during study, pregnant or wishing to become pregnant 3 months before or during the study

Design outcomes

Primary

MeasureTime frameDescription
Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut TreatmentsChange from baseline for each timepoint (60, 120, 240, 360 min)On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and CRP measured at 0, 60, 120, 240, and 360 min. Serum CRP was measured by latex-enhanced immunonephelometry. Several blood samples (n=3) could not be obtained/measured (walnut oil/120 min, whole walnut/240 min, and walnut skin/360 min).
Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut TreatmentsAUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and FRAP was measured at 0, 60, 120, 240, and 360 min. The FRAP assay was used to determine the reducing ability of plasma in a redox-linked colorimetric reaction. Plasma was incubated with the FRAP reagent at room temperature for 1 h and the absorbance at 593 nm was then recorded. Trolox was used as a reference to construct a standard curve to calculate the FRAP value of the samples. The FRAP assay measures lipophilic and hydrophilic antioxidants (total antioxidant capacity), both of which are present in walnuts.
Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut TreatmentsChange from baseline for each timepoint (60, 120, 240, 360 min)On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) blood sample was collected. Participants then had 15 min to consume 1 of 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and FRAP was measured at 0, 60, 120, 240, and 360 min. The FRAP assay was used to determine the reducing ability of plasma in a redox-linked colorimetric reaction. Plasma was incubated with the FRAP reagent at room temperature for 1 h and the absorbance at 593 nm was then recorded. Trolox was used as a reference to construct a standard curve to calculate the FRAP value of the samples. The FRAP assay measures lipophilic and hydrophilic antioxidants (total antioxidant capacity), both of which are present in walnuts. Several blood samples (n=3) could not be obtained/measured (walnut skin group at 360 min, walnut oil group at 120 min, whole walnut group at 240 min).
Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut TreatmentsAUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and total thiols measured at 0, 60, 120, 240, and 360 min. Total thiols in plasma were determined by the following methods: an aliquot of EDTA plasma was mixed with Tris-EDTA buffer, followed by addition of 10 mmol/L 2,2-dithiobisnitrobenzoic acid and methanol. After incubation at room temperature for 15 min and centrifugation, the absorbance of the supernatant was measured at 412 nm.
Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut TreatmentsChange from baseline for each timepoint (60, 120, 240, 360 min)On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and total thiols measured at 0, 60, 120, 240, and 360 min. Total thiols in plasma were determined by the following methods: an aliquot of EDTA plasma was mixed with Tris-EDTA buffer, followed by addition of 10 mmol/L 2,2-dithiobisnitrobenzoic acid and methanol. After incubation at room temperature for 15 min and centrifugation, the absorbance of the supernatant was measured at 412 nm. Several blood samples (n=3) could not be obtained/measured (walnut skin group at 360 min, walnut oil group at 120 min, whole walnut group at 240 min).
Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut TreatmentsAUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and MDA measured at 0, 60, 120, 240, and 360 min. Plasma MDA was measured by an Agilent 1100 HPLC system with fluorometric detection.
Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut TreatmentsChange from baseline for each timepoint (60, 120, 240, 360 min)On the day of each test, participants arrived at the clinic after a 12-h overnight fast. A baseline (0 min) blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and MDA measured at 0, 60, 120, 240, and 360 min. Plasma MDA was measured by an Agilent 1100 HPLC system with fluorometric detection. Several blood samples (n=2) could not be obtained (walnut oil group at 120 min and whole walnut group at 240 min).
Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut TreatmentsAUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and CRP measured at 0, 60, 120, 240, and 360 min. Serum CRP was measured by latex-enhanced immunonephelometry.

Secondary

MeasureTime frameDescription
Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut TreatmentsChange from baseline at 240 minOn the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. fRHI is an alternative calculation derived from the same raw data (as RHI) and differs in that it uses the period from 90 to 120 s of postocclusion hyperemia, does not incorporate a baseline correction factor, and has a natural log transformation applied to the resulting ratio. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.
Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut TreatmentsChange from baseline at 240 minOn the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.
Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut TreatmentsChange from baseline at 240 minOn the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. AI is a measure of vascular stiffness (pulse wave reflection) that is calculated from the shape of the pulse wave recorded during baseline. No endothelial function test data was available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.
Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut TreatmentsChange from baseline at 240 minOn the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. AI is a measure of vascular stiffness (pulse wave reflection) that is calculated from the shape of the pulse wave recorded during baseline. AI can be adjusted to a heart rate of 75 beats/min (AI\_75) to correct for the independent effect of heart rate on this measure.No endothelial function test data was available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.
Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut TreatmentsAUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and TG was measured at 0, 30, 60, 120, 240, and 360 min. TG were determined by standard colorimetric and enzymatic procedures with commercially available kits (Alfa Wassermann).
Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut TreatmentsChange from baseline for each timepoint (30, 60, 120, 240, 360 min)On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and TG was measured at 0, 30, 60, 120, 240, and 360 min. TG were determined by standard colorimetric and enzymatic procedures with commercially available kits (Alfa Wassermann). Several blood samples (n=4) could not be obtained/measured \[walnut skin group at 360 min (n=1), walnut oil group at 120 min (n=2), whole walnut group at 240 min(n=1)\].
Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut TreatmentsChange from baseline at 240 minOn the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. RHI was calculated as the ratio of the average pulse wave amplitude during hyperemia (60 to 120 s of the post occlusion period) to the average pulse wave amplitude during baseline in the occluded hand divided by the same values in the control hand and then multiplied by a baseline correction factor. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Countries

United States

Participant flow

Recruitment details

Participants were recruited through advertisements in the local newspaper and university e-mails from April 2008 to October 2008.

Pre-assignment details

Of the individuals (n=246) who were contacted and screened with a semi-structured telephone interview, 50 qualified and were scheduled for a screening visit at the Penn State General Clinical Research Center. After written informed consent was obtained, a fasting blood sample was drawn. Eligible participants (n=20) were randomized to the study.

Participants by arm

ArmCount
All Completed Participants (n=15)
Whole walnut (85 g) Walnut skins (5.6 g) Walnut oil (51 g) Defatted walnut nutmeat (34 g)
15
Total15

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1
Overall StudyProtocol Violation1
Overall StudyWithdrawal by Subject3

Baseline characteristics

CharacteristicAll Completed Participants (n=15)
Age, Continuous49 years
STANDARD_DEVIATION 9
Body mass index29 kg/m^2
STANDARD_DEVIATION 4
Diastolic blood pressure76 mm Hg
STANDARD_DEVIATION 9
Ferric reducing antioxidant potential (FRAP)1148 umol TE/L
STANDARD_DEVIATION 195
Framingham reactive hyperemia index (fRHI)0.43 ln(ratio)
STANDARD_DEVIATION 0.39
HDL-cholesterol1.1 mmol/L
STANDARD_DEVIATION 0.3
LDL-cholesterol3.4 mmol/L
STANDARD_DEVIATION 0.6
Malondialdehyde (MDA)0.75 umol/L
STANDARD_DEVIATION 0.32
Reactive hyperemia index (RHI)2.0 ratio
STANDARD_DEVIATION 0.6
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
6 Participants
Systolic blood pressure119 mm Hg
STANDARD_DEVIATION 10
Total cholesterol5.0 mmol/L
STANDARD_DEVIATION 0.7
Total thiols0.40 mmol/L
STANDARD_DEVIATION 0.11
Triglycerides1.2 mmol/L
STANDARD_DEVIATION 0.5

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
9 / 150 / 150 / 150 / 15
serious
Total, serious adverse events
0 / 150 / 150 / 150 / 15

Outcome results

Primary

Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and CRP measured at 0, 60, 120, 240, and 360 min. Serum CRP was measured by latex-enhanced immunonephelometry. Several blood samples (n=3) could not be obtained/measured (walnut oil/120 min, whole walnut/240 min, and walnut skin/360 min).

Time frame: Change from baseline for each timepoint (60, 120, 240, 360 min)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.12 mg/LStandard Error 0.05
Walnut Skins (5.6 g)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.08 mg/LStandard Error 0.05
Walnut Oil (51 g)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.06 mg/LStandard Error 0.09
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.16 mg/LStandard Error 0.12
Walnut Skins (60 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.04 mg/LStandard Error 0.06
Walnut Skins (120 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.03 mg/LStandard Error 0.05
Walnut Skins (240 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.04 mg/LStandard Error 0.09
Walnut Skins (360 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments-0.06 mg/LStandard Error 0.13
Walnut Oil (60 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.20 mg/LStandard Error 0.06
Walnut Oil (120 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.20 mg/LStandard Error 0.05
Walnut Oil (240 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.18 mg/LStandard Error 0.09
Walnut Oil (360 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.25 mg/LStandard Error 0.13
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.12 mg/LStandard Error 0.06
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.09 mg/LStandard Error 0.06
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.08 mg/LStandard Error 0.09
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on C-reactive Protein (CRP) Changes in Response to 4 Walnut Treatments0.20 mg/LStandard Error 0.13
p-value: >0.05Mixed Models Analysis
Primary

Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the clinic after a 12-h overnight fast. A baseline (0 min) blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and MDA measured at 0, 60, 120, 240, and 360 min. Plasma MDA was measured by an Agilent 1100 HPLC system with fluorometric detection. Several blood samples (n=2) could not be obtained (walnut oil group at 120 min and whole walnut group at 240 min).

Time frame: Change from baseline for each timepoint (60, 120, 240, 360 min)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.081 umol/LStandard Error 0.056
Walnut Skins (5.6 g)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.018 umol/LStandard Error 0.054
Walnut Oil (51 g)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.022 umol/LStandard Error 0.061
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.063 umol/LStandard Error 0.075
Walnut Skins (60 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.054 umol/LStandard Error 0.056
Walnut Skins (120 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.047 umol/LStandard Error 0.054
Walnut Skins (240 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.012 umol/LStandard Error 0.06
Walnut Skins (360 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.049 umol/LStandard Error 0.075
Walnut Oil (60 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.057 umol/LStandard Error 0.056
Walnut Oil (120 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.032 umol/LStandard Error 0.056
Walnut Oil (240 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.021 umol/LStandard Error 0.06
Walnut Oil (360 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.111 umol/LStandard Error 0.075
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.017 umol/LStandard Error 0.056
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments0.004 umol/LStandard Error 0.054
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.002 umol/LStandard Error 0.06
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on Malondialdehyde (MDA) Changes in Response to 4 Walnut Treatments-0.032 umol/LStandard Error 0.075
p-value: >0.05Mixed Models Analysis
Primary

Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) blood sample was collected. Participants then had 15 min to consume 1 of 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and FRAP was measured at 0, 60, 120, 240, and 360 min. The FRAP assay was used to determine the reducing ability of plasma in a redox-linked colorimetric reaction. Plasma was incubated with the FRAP reagent at room temperature for 1 h and the absorbance at 593 nm was then recorded. Trolox was used as a reference to construct a standard curve to calculate the FRAP value of the samples. The FRAP assay measures lipophilic and hydrophilic antioxidants (total antioxidant capacity), both of which are present in walnuts. Several blood samples (n=3) could not be obtained/measured (walnut skin group at 360 min, walnut oil group at 120 min, whole walnut group at 240 min).

Time frame: Change from baseline for each timepoint (60, 120, 240, 360 min)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments69 umol Trolox equivalents (TE)/LStandard Error 63
Walnut Skins (5.6 g)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-34 umol Trolox equivalents (TE)/LStandard Error 63
Walnut Oil (51 g)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-65 umol Trolox equivalents (TE)/LStandard Error 64
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-75 umol Trolox equivalents (TE)/LStandard Error 63
Walnut Skins (60 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-4 umol Trolox equivalents (TE)/LStandard Error 64
Walnut Skins (120 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments10 umol Trolox equivalents (TE)/LStandard Error 64
Walnut Skins (240 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments7 umol Trolox equivalents (TE)/LStandard Error 64
Walnut Skins (360 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments98 umol Trolox equivalents (TE)/LStandard Error 65
Walnut Oil (60 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-10 umol Trolox equivalents (TE)/LStandard Error 64
Walnut Oil (120 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments5 umol Trolox equivalents (TE)/LStandard Error 65
Walnut Oil (240 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments53 umol Trolox equivalents (TE)/LStandard Error 64
Walnut Oil (360 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-13 umol Trolox equivalents (TE)/LStandard Error 64
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-139 umol Trolox equivalents (TE)/LStandard Error 66
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-92 umol Trolox equivalents (TE)/LStandard Error 66
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-175 umol Trolox equivalents (TE)/LStandard Error 66
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-134 umol Trolox equivalents (TE)/LStandard Error 66
p-value: 0.15Mixed Models Analysis
Primary

Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and total thiols measured at 0, 60, 120, 240, and 360 min. Total thiols in plasma were determined by the following methods: an aliquot of EDTA plasma was mixed with Tris-EDTA buffer, followed by addition of 10 mmol/L 2,2-dithiobisnitrobenzoic acid and methanol. After incubation at room temperature for 15 min and centrifugation, the absorbance of the supernatant was measured at 412 nm. Several blood samples (n=3) could not be obtained/measured (walnut skin group at 360 min, walnut oil group at 120 min, whole walnut group at 240 min).

Time frame: Change from baseline for each timepoint (60, 120, 240, 360 min)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.051 mmol/LStandard Error 0.017
Walnut Skins (5.6 g)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.035 mmol/LStandard Error 0.017
Walnut Oil (51 g)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.001 mmol/LStandard Error 0.021
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.010 mmol/LStandard Error 0.022
Walnut Skins (60 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.018 mmol/LStandard Error 0.018
Walnut Skins (120 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments-0.004 mmol/LStandard Error 0.018
Walnut Skins (240 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.005 mmol/LStandard Error 0.021
Walnut Skins (360 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.019 mmol/LStandard Error 0.023
Walnut Oil (60 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.022 mmol/LStandard Error 0.017
Walnut Oil (120 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.029 mmol/LStandard Error 0.018
Walnut Oil (240 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.003 mmol/LStandard Error 0.02
Walnut Oil (360 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments-0.010 mmol/LStandard Error 0.023
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.038 mmol/LStandard Error 0.019
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.037 mmol/LStandard Error 0.02
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.022 mmol/LStandard Error 0.022
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on Total Thiol Changes in Response to 4 Walnut Treatments0.008 mmol/LStandard Error 0.024
p-value: 0.53Mixed Models Analysis
Primary

Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and CRP measured at 0, 60, 120, 240, and 360 min. Serum CRP was measured by latex-enhanced immunonephelometry.

Time frame: AUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut Treatments0.10 mg*min/LStandard Error 0.07
Walnut Skins (5.6 g)Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut Treatments0.01 mg*min/LStandard Error 0.07
Walnut Oil (51 g)Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut Treatments0.20 mg*min/LStandard Error 0.07
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on the Changes in C-reactive Protein (CRP) Response to 4 Walnut Treatments0.12 mg*min/LStandard Error 0.07
p-value: >0.05Mixed Models Analysis
Primary

Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and MDA measured at 0, 60, 120, 240, and 360 min. Plasma MDA was measured by an Agilent 1100 HPLC system with fluorometric detection.

Time frame: AUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut Treatments-0.015 umol*min/LStandard Error 0.036
Walnut Skins (5.6 g)Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut Treatments0.004 umol*min/LStandard Error 0.036
Walnut Oil (51 g)Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut Treatments0.041 umol*min/LStandard Error 0.036
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on the Changes in Malondialdehyde (MDA) Response to 4 Walnut Treatments-0.001 umol*min/LStandard Error 0.037
p-value: >0.05Mixed Models Analysis
Primary

Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and total thiols measured at 0, 60, 120, 240, and 360 min. Total thiols in plasma were determined by the following methods: an aliquot of EDTA plasma was mixed with Tris-EDTA buffer, followed by addition of 10 mmol/L 2,2-dithiobisnitrobenzoic acid and methanol. After incubation at room temperature for 15 min and centrifugation, the absorbance of the supernatant was measured at 412 nm.

Time frame: AUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut Treatments0.024 mmol*min/LStandard Error 0.014
Walnut Skins (5.6 g)Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut Treatments0.010 mmol*min/LStandard Error 0.015
Walnut Oil (51 g)Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut Treatments0.011 mmol*min/LStandard Error 0.014
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on the Changes in Total Thiol Response to 4 Walnut Treatments0.026 mmol*min/LStandard Error 0.017
p-value: 0.79Mixed Models Analysis
Primary

Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and FRAP was measured at 0, 60, 120, 240, and 360 min. The FRAP assay was used to determine the reducing ability of plasma in a redox-linked colorimetric reaction. Plasma was incubated with the FRAP reagent at room temperature for 1 h and the absorbance at 593 nm was then recorded. Trolox was used as a reference to construct a standard curve to calculate the FRAP value of the samples. The FRAP assay measures lipophilic and hydrophilic antioxidants (total antioxidant capacity), both of which are present in walnuts.

Time frame: AUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-26 umol Trolox equivalents (TE)*min/LStandard Error 46
Walnut Skins (5.6 g)Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments28 umol Trolox equivalents (TE)*min/LStandard Error 47
Walnut Oil (51 g)Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments9 umol Trolox equivalents (TE)*min/LStandard Error 47
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on the Ferric Reducing Antioxidant Potential (FRAP) Changes in Response to 4 Walnut Treatments-135 umol Trolox equivalents (TE)*min/LStandard Error 51
p-value: <0.01Mixed Models Analysis
p-value: 0.15Mixed Models Analysis
p-value: 0.35Mixed Models Analysis
p-value: 0.011Mixed Models Analysis
p-value: 0.62Mixed Models Analysis
p-value: 0.0002Mixed Models Analysis
p-value: 0.0013Mixed Models Analysis
Secondary

Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and TG was measured at 0, 30, 60, 120, 240, and 360 min. TG were determined by standard colorimetric and enzymatic procedures with commercially available kits (Alfa Wassermann). Several blood samples (n=4) could not be obtained/measured \[walnut skin group at 360 min (n=1), walnut oil group at 120 min (n=2), whole walnut group at 240 min(n=1)\].

Time frame: Change from baseline for each timepoint (30, 60, 120, 240, 360 min)

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.04 mmol/LStandard Error 0.04
Walnut Skins (5.6 g)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.13 mmol/LStandard Error 0.05
Walnut Oil (51 g)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.32 mmol/LStandard Error 0.07
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.47 mmol/LStandard Error 0.08
Walnut Skins (60 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.24 mmol/LStandard Error 0.07
Walnut Skins (120 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.05 mmol/LStandard Error 0.04
Walnut Skins (240 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.05 mmol/LStandard Error 0.05
Walnut Skins (360 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.02 mmol/LStandard Error 0.07
Walnut Oil (60 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.06 mmol/LStandard Error 0.08
Walnut Oil (120 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.08 mmol/LStandard Error 0.07
Walnut Oil (240 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.08 mmol/LStandard Error 0.04
Walnut Oil (360 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.10 mmol/LStandard Error 0.05
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.41 mmol/LStandard Error 0.07
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.47 mmol/LStandard Error 0.08
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.14 mmol/LStandard Error 0.07
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.05 mmol/LStandard Error 0.05
Defatted Walnut Nutmeat (60 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.02 mmol/LStandard Error 0.06
Defatted Walnut Nutmeat (120 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.06 mmol/LStandard Error 0.07
Defatted Walnut Nutmeat (240 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.17 mmol/LStandard Error 0.09
Defatted Walnut Nutmeat (360 Min)Main Effect of Treatment by Timepoint on Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.13 mmol/LStandard Error 0.08
p-value: <0.0001Mixed Models Analysis
p-value: 0.91Mixed Models Analysis
p-value: 0.21Mixed Models Analysis
p-value: 0.0011Mixed Models Analysis
p-value: 0.0004Mixed Models Analysis
p-value: 0.11Mixed Models Analysis
p-value: 0.53Mixed Models Analysis
p-value: 0.59Mixed Models Analysis
p-value: 0.31Mixed Models Analysis
p-value: 0.98Mixed Models Analysis
p-value: 0.3Mixed Models Analysis
p-value: 0.91Mixed Models Analysis
p-value: 0.12Mixed Models Analysis
p-value: 0.007Mixed Models Analysis
p-value: 0.0089Mixed Models Analysis
p-value: 0.28Mixed Models Analysis
p-value: 0.62Mixed Models Analysis
p-value: 0.48Mixed Models Analysis
p-value: <0.0001Mixed Models Analysis
p-value: 0.0003Mixed Models Analysis
p-value: 0.57Mixed Models Analysis
p-value: 0.99Mixed Models Analysis
p-value: 0.71Mixed Models Analysis
p-value: 0.62Mixed Models Analysis
p-value: 0.33Mixed Models Analysis
p-value: 0.65Mixed Models Analysis
p-value: 0.66Mixed Models Analysis
p-value: 0.3Mixed Models Analysis
p-value: 0.0005Mixed Models Analysis
p-value: 0.0085Mixed Models Analysis
p-value: 0.92Mixed Models Analysis
Secondary

Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. AI is a measure of vascular stiffness (pulse wave reflection) that is calculated from the shape of the pulse wave recorded during baseline. No endothelial function test data was available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Time frame: Change from baseline at 240 min

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut Treatments-6.6 Percent changeStandard Error 3.1
Walnut Skins (5.6 g)Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut Treatments-1.4 Percent changeStandard Error 3.2
Walnut Oil (51 g)Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut Treatments-2.6 Percent changeStandard Error 3.2
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on Augmentation Index (AI) Changes in Response to 4 Walnut Treatments-4.0 Percent changeStandard Error 3.7
p-value: 0.44Mixed Models Analysis
Secondary

Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. AI is a measure of vascular stiffness (pulse wave reflection) that is calculated from the shape of the pulse wave recorded during baseline. AI can be adjusted to a heart rate of 75 beats/min (AI\_75) to correct for the independent effect of heart rate on this measure.No endothelial function test data was available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Time frame: Change from baseline at 240 min

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut Treatments-4.0 Percent changeStandard Error 2.7
Walnut Skins (5.6 g)Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut Treatments-1.2 Percent changeStandard Error 2.8
Walnut Oil (51 g)Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut Treatments-0.1 Percent changeStandard Error 2.9
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on Augmentation Index Standardized to a Heart Rate of 75 Beats/Min (AI_75) Changes in Response to 4 Walnut Treatments-2.9 Percent changeStandard Error 3.3
p-value: 0.62Mixed Models Analysis
Secondary

Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. fRHI is an alternative calculation derived from the same raw data (as RHI) and differs in that it uses the period from 90 to 120 s of postocclusion hyperemia, does not incorporate a baseline correction factor, and has a natural log transformation applied to the resulting ratio. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Time frame: Change from baseline at 240 min

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut Treatments-0.14 ln(ratio)Standard Error 0.07
Walnut Skins (5.6 g)Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut Treatments-0.14 ln(ratio)Standard Error 0.07
Walnut Oil (51 g)Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut Treatments0.09 ln(ratio)Standard Error 0.07
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on Framingham Reactive Hyperemia Index (fRHI) Changes in Response to 4 Walnut Treatments-0.02 ln(ratio)Standard Error 0.07
p-value: 0.01Mixed Models Analysis
p-value: 0.98Mixed Models Analysis
p-value: 0.004Mixed Models Analysis
p-value: 0.11Mixed Models Analysis
p-value: 0.004Mixed Models Analysis
p-value: 0.11Mixed Models Analysis
p-value: 0.16Mixed Models Analysis
Secondary

Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Time frame: Change from baseline at 240 min

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut Treatments3.9 beats/minuteStandard Error 1.4
Walnut Skins (5.6 g)Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut Treatments0.2 beats/minuteStandard Error 1.4
Walnut Oil (51 g)Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut Treatments4.4 beats/minuteStandard Error 1.4
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on Heart Rate (HR) Changes in Response to 4 Walnut Treatments1.9 beats/minuteStandard Error 1.5
p-value: 0.14Mixed Models Analysis
p-value: 0.002Mixed Models Analysis
p-value: 0.22Mixed Models Analysis
p-value: 0.074Mixed Models Analysis
p-value: 0.007Mixed Models Analysis
p-value: 0.004Mixed Models Analysis
p-value: 0.62Mixed Models Analysis
Secondary

Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. At baseline the endothelial function test was performed using pulse amplitude tonometry (PAT) (Itamar Medical). Participants then had 15 min to consume 1 of the 4 walnut test meals. The endothelial function test was performed again at 240 min postmeal. RHI was calculated as the ratio of the average pulse wave amplitude during hyperemia (60 to 120 s of the post occlusion period) to the average pulse wave amplitude during baseline in the occluded hand divided by the same values in the control hand and then multiplied by a baseline correction factor. No endothelial function test data available for one participant within the walnut oil group and one within the defatted walnut nutmeat group.

Time frame: Change from baseline at 240 min

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut Treatments-0.19 ratioStandard Error 0.09
Walnut Skins (5.6 g)Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut Treatments-0.26 ratioStandard Error 0.09
Walnut Oil (51 g)Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut Treatments0.07 ratioStandard Error 0.09
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on Reactive Hyperemia Index (RHI) Changes in Response to 4 Walnut Treatments-0.09 ratioStandard Error 0.09
p-value: 0.012Mixed Models Analysis
p-value: 0.52Mixed Models Analysis
p-value: 0.011Mixed Models Analysis
p-value: 0.29Mixed Models Analysis
p-value: 0.002Mixed Models Analysis
p-value: 0.093Mixed Models Analysis
p-value: 0.12Mixed Models Analysis
Secondary

Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut Treatments

On the day of each test, participants arrived at the General Clinical Research Center after a 12-h overnight fast. A baseline (0 min) fasting blood sample was collected. Participants then had 15 min to consume 1 of the 4 walnut test meals. Blood samples (∼30 mL) were subsequently taken at 30, 60, 120, 240, and 360 min following the meal and TG was measured at 0, 30, 60, 120, 240, and 360 min. TG were determined by standard colorimetric and enzymatic procedures with commercially available kits (Alfa Wassermann).

Time frame: AUC values were calculated with the trapezoidal rule, using the respective fasting baseline value as the line of reference. Measured at 0 to 360 min (baseline to 360min post meal) for each of the 4 walnut treatments.

Population: All participants who completed each of the 4 treatment arms

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Whole Walnut (85 g)Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.24 mmol*min/LStandard Error 0.05
Walnut Skins (5.6 g)Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.05 mmol*min/LStandard Error 0.05
Walnut Oil (51 g)Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.24 mmol*min/LStandard Error 0.05
Defatted Walnut Nutmeat (34 g)Main Effect of Treatment on the Triglyceride (TG) Changes in Response to 4 Walnut Treatments0.09 mmol*min/LStandard Error 0.06
p-value: 0.011Mixed Models Analysis
p-value: 0.007Mixed Models Analysis
p-value: 0.99Mixed Models Analysis
p-value: 0.037Mixed Models Analysis
p-value: 0.0087Mixed Models Analysis
p-value: 0.64Mixed Models Analysis
p-value: 0.043Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 28, 2026